-
Sorainen successfully represented Nasdaq CSD SE, the defendant in litigation initiated by AS Grindeks. Grindeks was seeking a court order to recover funds from Nasdaq CSD that had been accrued for shareholder dividend payments. About the case In 2020, Grindeks shareholders resolved to delist the company’s shares from the regulated market – the Nasdaq Riga […]
-
We advised Alchemy, a leading global Web3 development platform, on the acquisition of DexterLab, an infrastructure developer specialising in solutions built on the Solana blockchain. DexterLab focuses on developing analytics and tooling that help decentralised application developers work more efficiently within the Solana ecosystem. The acquisition will enable Alchemy to further expand its services for […]
-
At the request of the Estonian Private Forest Association, we assessed the constitutionality of proposed amendments to the Nature Conservation Act. The planned amendments would register areas under consideration for protection without a substantive decision. This step would immediately reduce the value of the land. The analysis revealed the planned amendments to be contrary to […]
-
We advised road traffic safety service provider Saferoad during the process of obtaining the clearance from the Lithuanian Competition Council for the acquisition of 100% shareholding in Lithuanian company GATAS. Commitments to preserve effective competition Taking into account the findings of the Competition Council, Saferoad submitted commitments to ensure fair supply conditions for all GATAS […]
-
We advised SafePAS on closing their first investment round at EUR 700,000. The funds will be used to accelerate the market launch of Drug Hunter, a game-changing portable drug detection analyser for onsite use, as well as other next-gen tools. Backing from Estonia and beyond In the investment round, investors from across Europe contributed Securetec […]
